Despite decades of use, the best cannabis approach for chronic pain remains unknown

A physician-focused review found that while most evidence supports cannabis for pain management, no head-to-head comparison exists between different cannabis preparations, leaving the optimal treatment approach unanswered.

RTHC-03977ReviewModerate Evidence2022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Most reviews concluded cannabis plays a significant role in pain management. Systematic studies do not support an "entourage effect" of other cannabis plant constituents for pain. CBD is the only cannabinoid that does not cause intoxication and is not a controlled substance. No head-to-head comparison exists between different cannabis cultivars, between pure cannabinoids, or between pure cannabinoids and extracts.

Key Numbers

Products range from defined cultivars (varying THC:CBD ratios) to pure cannabinoids (THC, CBD) to standardized mixtures (nabiximols, 1:1 THC:CBD). Zero head-to-head comparisons published.

How They Did This

Review examining cannabis and cannabinoid preparations for chronic pain from the physician perspective, covering available preparations (cultivars, extracts, nabiximols, pure CBD/THC), evidence base, and clinical knowledge gaps.

Why This Research Matters

Physicians must choose between very different cannabis products with no comparative evidence. The finding that the "entourage effect" lacks systematic support for pain challenges a major marketing claim.

The Bigger Picture

Despite thousands of years of cannabis use for pain and growing modern legalization, the most basic clinical question, which preparation works best, remains unanswered.

What This Study Doesn't Tell Us

Narrative review without systematic methodology. Conflicting opinions in the literature acknowledged. Pain is heterogeneous, making generalized recommendations difficult.

Questions This Raises

  • ?Why have no head-to-head trials been conducted?
  • ?Would standardized cannabis preparations enable better clinical comparisons?

Trust & Context

Key Stat:
Zero head-to-head comparisons between cannabis preparations for pain
Evidence Grade:
Physician-focused review synthesizing existing evidence but noting the absence of comparative clinical trials.
Study Age:
Published in 2022.
Original Title:
The Role of Cannabis, Cannabidiol and Other Cannabinoids in Chronic Pain. The Perspective of Physicians.
Published In:
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 17(1-2), 318-333 (2022)
Database ID:
RTHC-03977

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Which form of cannabis works best for pain?

Nobody knows. This review found that no head-to-head comparison has been published between different cannabis cultivars, pure cannabinoids, or extracts for chronic pain treatment.

Does the entourage effect help with pain?

Systematic studies to date do not support an entourage effect of other plant constituents (mainly terpenoids) for pain treatment, despite widespread marketing claims.

Read More on RethinkTHC

Cite This Study

RTHC-03977·https://rethinkthc.com/research/RTHC-03977

APA

Köstenberger, Markus; Nahler, Gerhard; Jones, Trevor M; Neuwersch, Stefan; Likar, Rudolf. (2022). The Role of Cannabis, Cannabidiol and Other Cannabinoids in Chronic Pain. The Perspective of Physicians.. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 17(1-2), 318-333. https://doi.org/10.1007/s11481-021-10010-x

MLA

Köstenberger, Markus, et al. "The Role of Cannabis, Cannabidiol and Other Cannabinoids in Chronic Pain. The Perspective of Physicians.." Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2022. https://doi.org/10.1007/s11481-021-10010-x

RethinkTHC

RethinkTHC Research Database. "The Role of Cannabis, Cannabidiol and Other Cannabinoids in ..." RTHC-03977. Retrieved from https://rethinkthc.com/research/kostenberger-2022-the-role-of-cannabis

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.